Type 2 diabetes mellitus with diabetic neuropathy, unspecified
ICD-10 E11.40 is a billable code used to indicate a diagnosis of type 2 diabetes mellitus with diabetic neuropathy, unspecified.
E11.40 refers to Type 2 diabetes mellitus characterized by the presence of diabetic neuropathy, a common complication that affects the peripheral nervous system. Patients with this condition may experience symptoms such as numbness, tingling, pain, or weakness in the extremities. The neuropathy can result from prolonged hyperglycemia, leading to nerve damage due to metabolic and vascular changes. The unspecified nature of this code indicates that the specific type or location of neuropathy is not documented, which can complicate management and treatment. Effective management of Type 2 diabetes involves controlling blood glucose levels, typically monitored through HbA1c levels, which should ideally be maintained below 7% to minimize complications. Insulin therapy may be required for some patients, especially if oral medications are insufficient. Regular monitoring for diabetic complications, including neuropathy, is essential for preventing further morbidity.
Detailed records of diabetes management, including medication regimens and HbA1c levels.
Patients presenting with uncontrolled diabetes and neuropathic symptoms.
Ensure comprehensive documentation of all diabetes-related complications.
Thorough neurological assessments and symptom descriptions.
Patients with neuropathic pain or sensory loss due to diabetes.
Document specific neurological findings to support coding.
Used for routine follow-up of diabetes management.
Document patient history, examination findings, and management plan.
Endocrinologists should ensure comprehensive diabetes management documentation.
The unspecified designation indicates that the specific type or location of diabetic neuropathy has not been documented, which can affect treatment and management decisions.
